Complete Response with Modified FLOX in Metastatic Colon Cancer: A Case Report

Lignende værker

• Autophagy inhibition improves sensitivity to the multi-kinase inhibitor regorafenib in preclinical mouse colon tumoroids
  af: Giulia Agostini, et al.
  Udgivet: (2025-07-01)
• Prognostic Factors Influencing the Efficacy of Regorafenib in the Treatment of Metastatic Colorectal Cancer
  af: Nadiye SEVER, et al.
  Udgivet: (2025-06-01)
• Prognostic factors influencing regorafenib treatment outcomes in metastatic colorectal cancer
  af: Ahmet Yolcu, et al.
  Udgivet: (2023-12-01)
• Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
  af: Wang Qu, et al.
  Udgivet: (2024-01-01)
• A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report
  af: Simona De Summa, et al.
  Udgivet: (2021-11-01)